Cadrenal Therapeutics (CVKD) Net Income (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Net Income of -$2.7 million for Q3 2024, down 13.86% sequentially from -$2.4 million in Q2 2024, and down 53.94% YoY from -$5.9 million in Q4 2023.
Cadrenal Therapeutics (CVKD) Net Income (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Net Income for 3 years, with the latest figure at -$2.7 million in Q3 2024.
- Quarterly Net Income fell 53.94% year-over-year to -$2.7 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$2.7 million (up 60.85% YoY) and the FY2023 annual result came in at -$8.4 million, down 24.47% from the prior year.
- Net Income slipped to -$2.7 million in Q3 2024 per CVKD's latest filing, from -$2.4 million in the prior quarter.
- Over five years, Net Income peaked at -$172602.0 in Q1 2022 and troughed at -$5.0 million in Q1 2023.
- A 3-year average of -$1.8 million and a median of -$1.7 million in 2024 frame the typical range for Net Income.
- The sharpest annual moves came in 2023 and 2024: Net Income tumbled 2801.9% in 2023, then jumped 66.78% in 2024.
- Over 3 years, Net Income stood at -$1.1 million in 2022, then retreated by 4.57% to -$1.1 million in 2023, then sank by 139.05% to -$2.7 million in 2024.
- According to Business Quant data, Net Income over the past three periods registered -$2.7 million, -$2.4 million, and -$1.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | -3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.33 Mn |
| Jun 30, 2025 | -3.86 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Jun 30, 2024 | -2.40 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.78 Mn |
| Jun 30, 2023 | -2.00 Mn |
| Mar 31, 2023 | -5.01 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | -986,332.00 |
| Jun 30, 2022 | -488,793.00 |
| Mar 31, 2022 | -172,602.00 |